Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,367
Closed -$294K 172
2025
Q2
$294K Sell
3,367
-787
-19% -$61.7K 0.03% 130
2025
Q1
$284K Buy
+4,154
New +$339K 0.03% 510
2024
Q3
Sell
-27,792
Closed -$3.15M 608
2024
Q2
$3.15M Buy
+27,792
New +$3.51M 0.06% 242
2022
Q1
Sell
-3,176
Closed -$426K 196
2021
Q4
$426K Buy
+3,176
New +$456K 0.01% 255

Other funds holding DXCM

MBB Public Markets's DXCM Position: Q3 2025 in Review

MBB Public Markets sold out of DexCom (DXCM) in Q3 2025, closing a stake of 3,367 shares — an estimated $294K sold.

MBB Public Markets first reported a position in DXCM in Q4 2021 and held it in 4 quarters. The position peaked at $3.15M in Q2 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • MBB Public Markets reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 3,367 DexCom shares in Q3 2025, an estimated $294K.
  • MBB Public Markets first reported a position in DexCom in Q4 2021 and held it in 4 quarters.
  • MBB Public Markets's DexCom position peaked at $3.15M in Q2 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.